Come up with a name for your new list and we'll add to it:
Quotient Bioresearch raised a round of funding on January 30, 2012. Investors include
Management Buyout (MBO).
Quotient Bioresearch is a provider of early stage and specialist drug development services to life science clients. The company provides tailored solutions for pharmaceutical, biotechnology and agroch…